# BioAtla

> BioAtla is a VC fund in San Diego backing Medical and Big Data. See 1 investments, check sizes, portfolio and contact details. Updated Sep 2026.

- Type: VC Fund
- Location: San Diego, United States
- Total investments: 1
- Last investment: Feb 2017
- Lead investor: 0%
- Last updated: Sep 2026
- LinkedIn: https://www.linkedin.com/company/bioatla
- Website: http://bioatla.com
- Facebook: https://www.facebook.com/pages/BioAtla-LLC/175225865910397

BioAtla is a VC fund in San Diego focused on Medical and Big Data. BioAtla develops safer, more effective drugs for cancer using a proprietary next-generation antibody discovery and evolution platform. BioAtla is a San Diego biotech company that develops novel monoclonal antibody and cell-based therapeutics using our proprietary Conditionally Active Biologics (CAB) and Comprehensive Integrated AntibodyOptimization (CIAO!) platforms. These and other proprietary technologies (protected by more than 150 issued patents and patent applications) allow them to develop novel biologics (CABs) that are better drugs in multiple ways including more selective targeting of cancer tissue and improved manufacturability. Improved selectivity for the tumor microenvironment, even when the target is also found in normal tissue, not only improves safety but also expands the universe of potential drug targets, enabling the treatment of previously untreatable cancers.

## Contacts

5 contacts available for BioAtla. Shizune tracks 5 team members at BioAtla. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/bioatla?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 1 | 100% |
| Big Data | 1 | 100% |
| Health Care | 1 | 100% |
| Biotechnology | 1 | 100% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Chris Vasquez | CFO and Principal Financial Officer; Chief Accounting Officer, Controller, Corporate Secretary | 0 | https://shizune.co/investors/profile/chris-vasquez-a818 |
| Eric Sievers | Chief Medical Officer | 0 | https://shizune.co/investors/profile/eric-sievers |
| Jay M. Short | Chairman, CEO and Cofounder | 0 | https://shizune.co/investors/profile/jay-m-short |
| Richard A. Waldron | Chief Financial Officer | 0 | https://shizune.co/investors/profile/richard-a-waldron |
| Scott A. Smith | President & Board Member | 0 | https://shizune.co/investors/profile/scott-a-smith |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Exuma Biotech | EXUMA Biotech is a clinical-stage biotechnology company discovering and developing Chimeric Antigen Receptor (CAR)-T cell products for solid tumors. They develop new tools for the patient’s immune system to fight various solid tumor malignancies, such as renal cell carcinoma, soft tissue sarcoma, gastric cancer, and others.It was founded in 2015and headquartered in Grand Cayman, Midland. | $37M | Series A | Feb 16, 2017 |  |

1 of 1 investments shown.

## Co-investors
- [F1 BioVentures](https://shizune.co/investors/profile/f1-bioventures) — VC Fund, 1 deal together
- [Sinobioway Group](https://shizune.co/investors/profile/sinobioway-group) — VC Fund, 1 deal together
- [SunTerra Capital](https://shizune.co/investors/profile/sunterra-capital) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund
- [Lightspeed Venture Partners](https://shizune.co/investors/profile/lightspeed-venture-partners) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [Wintermute Ventures](https://shizune.co/investors/profile/wintermute-ventures) — VC Fund
- [Wintermute](https://shizune.co/investors/profile/wintermute-trading) — VC Fund
- [1confirmation](https://shizune.co/investors/profile/1confirmation) — VC Fund

## Featured in investor lists
- [Big Data Investors in Cayman Islands](https://shizune.co/investors/big-data-investors-cayman-islands)
- [Big Data VC Funds in Cayman Islands](https://shizune.co/investors/big-data-vc-funds-cayman-islands)
- [Medical Investors in Cayman Islands](https://shizune.co/investors/medical-investors-cayman-islands)
- [Medical VC Funds in Cayman Islands](https://shizune.co/investors/medical-vc-funds-cayman-islands)

## FAQ

### What does BioAtla invest in?

BioAtla invests primarily in Medical, Big Data and Health Care startups, most often at Series A stage. Most of the 1 investments tracked by Shizune back companies in Cayman Islands. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact BioAtla?

Public channels for BioAtla include LinkedIn, the website linked on this profile and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at BioAtla?

The team at BioAtla includes Chris Vasquez (CFO and Principal Financial Officer; Chief Accounting Officer, Controller, Corporate Secretary), Eric Sievers (Chief Medical Officer) and Jay M. Short (Chairman, CEO and Cofounder). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co